Latest Breaking News On - Group limited merger sub - Page 1 : vimarsana.com

China Biologic Announces Shareholders Approval of Merger Agreement News provided by Share this article Share this article BEIJING, March 1, 2021 /PRNewswire/ China Biologic Products Holdings, Inc. (NASDAQ: CBPO, China Biologic or the Company ), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that, at an extraordinary general meeting (the EGM ) held today, the Company s shareholders voted in favor of the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of November 19, 2020 (the Merger Agreement ), among the Company, CBPO Holdings Limited ( Parent ) and CBPO Group Limited ( Merger Sub ), pursuant to which, Merger Sub will be merged with and into the Company with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent (the Merger ), the plan of merger (the Plan of Merger ) required to be filed with the Registrar of Companies of the Cayma

Ming yinCayman islandsPhilip lisioShandong taibang biological products co ltdHoldings limited parentPrnewswire china biologic products holdings incRegistrar of companies the caymanGuizhou taibang biological products co ltdGroup limited merger subSecurities exchangeChina biologic products holdings incTianxinfu beijing medical appliance co ltdFoote groupXian huitian blood products co ltdBiologic products holdingsMerger sub